Patients with NF1 are also at increased risk of developing myeloid leukemia and other genotoxin-induced malignancies [17], and homozygous mutations in NF1 were recently reported in a subset of adult acute myelogenous leukemias (AML) [14]. The gene discussed is NF1; the disease is myeloid leukemia.